Warby Parker (WRBY) Non-Current Assets (2020 - 2026)
Warby Parker (WRBY) posted Non-Current Assets of $378.7 million for Q1 2026, up 2.78% on a QoQ basis from $368.5 million in Q4 2025, and up 7.54% year-over-year from $352.2 million in Q1 2025.
Warby Parker (WRBY) Non-Current Assets (2020 - 2026) Analysis & Trends
Warby Parker's Non-Current Assets history runs 7 years deep, the most recent figure standing at $378.7 million for Q1 2026.
- Quarterly Non-Current Assets rose 7.54% year-over-year to $378.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 10.3% YoY) and the FY2025 annual result came in at $368.5 million, up 5.15% from the prior year.
- Non-Current Assets was $378.7 million for Q1 2026 at Warby Parker, up from $368.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $378.7 million in Q1 2026 and bottomed at $232.5 million in Q1 2022.
- A 5-year average of $307.2 million and a median of $296.8 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 152.61% — and 2023, when it rose 2.76%.
- Warby Parker's Non-Current Assets stood at $274.1 million in 2022, then gained by 2.76% to $281.7 million in 2023, then rose by 24.41% to $350.4 million in 2024, then climbed by 5.15% to $368.5 million in 2025, then gained by 2.78% to $378.7 million in 2026.
- Business Quant data shows WRBY's Non-Current Assets at $378.7 million in Q1 2026, $368.5 million in Q4 2025, and $362.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | 378.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.72 Mn |
| Dec 31, 2025 | 368.48 Mn |
| Sep 30, 2025 | 362.86 Mn |
| Jun 30, 2025 | 355.80 Mn |
| Mar 31, 2025 | 352.16 Mn |
| Dec 31, 2024 | 350.44 Mn |
| Sep 30, 2024 | 316.78 Mn |
| Jun 30, 2024 | 309.57 Mn |
| Mar 31, 2024 | 296.78 Mn |
| Dec 31, 2023 | 281.69 Mn |
| Sep 30, 2023 | 279.40 Mn |
| Jun 30, 2023 | 273.67 Mn |
| Mar 31, 2023 | 273.32 Mn |
| Dec 31, 2022 | 274.14 Mn |
| Sep 30, 2022 | 267.94 Mn |
| Jun 30, 2022 | 247.75 Mn |
| Mar 31, 2022 | 232.51 Mn |
| Dec 31, 2021 | 112.67 Mn |
| Sep 30, 2021 | 106.07 Mn |
| Dec 31, 2020 | 84.82 Mn |